These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26800999)

  • 1. Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.
    Kim JG; Song KD; Kim SH; Kim HC; Huh JW
    J Magn Reson Imaging; 2016 Aug; 44(2):471-7. PubMed ID: 26800999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.
    Huang SH; Chi P; Lin HM; Lu XR; Huang YW; Xu ZB; Sun YW; Ye DX; Wang XJ; Wang X
    Colorectal Dis; 2016 Oct; 18(10):989-996. PubMed ID: 26880193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study.
    Yang IJ; Suh JW; Lee J; Ahn HM; Oh HK; Kim DW; Kim MJ; Ryoo SB; Jeong SY; Park KJ; Lee DW; Park SC; Park HC; Oh JH; Kang SB
    Int J Colorectal Dis; 2022 Jul; 37(7):1561-1568. PubMed ID: 35648208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?
    Dresen RC; Beets GL; Rutten HJ; Engelen SM; Lahaye MJ; Vliegen RF; de Bruïne AP; Kessels AG; Lammering G; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):71-80. PubMed ID: 19403847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
    Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
    Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
    Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer?
    Joye I; Debucquoy A; Fieuws S; Wolthuis A; Sagaert X; D'Hoore A; Haustermans K
    Acta Oncol; 2016 Aug; 55(8):1047-52. PubMed ID: 27142064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.
    Wan J; Liu K; Zhu J; Li G; Zhang Z
    Oncotarget; 2015 May; 6(13):11714-22. PubMed ID: 25909169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer.
    Joye I; Debucquoy A; Deroose CM; Vandecaveye V; Cutsem EV; Wolthuis A; D'Hoore A; Sagaert X; Zhou M; Gevaert O; Haustermans K
    Radiother Oncol; 2017 Jul; 124(1):104-109. PubMed ID: 28647399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
    Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
    Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
    Wang Y; Wang X; Huang S; Chen J; Huang Y
    ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
    Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
    Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.